{
    "2021-03-02": [
        [
            {
                "time": "",
                "original_text": "上海莱士(002252.SZ)：控股股东及一致行动人被动减持6.781%股份 减持股份",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "控股股东",
                        "一致行动人",
                        "被动减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士：股东莱士中国累计被动减持4.57%股份 减持股份",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "股东",
                        "莱士中国",
                        "被动减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海莱士：控股股东莱士中国及其一致行动人被动减持约3.08亿股 减持股份",
                "features": {
                    "keywords": [
                        "上海莱士",
                        "控股股东",
                        "莱士中国",
                        "一致行动人",
                        "被动减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物33亿元定增争议",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "定增",
                        "争议"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}